Study highlights costs associated with heart failure, acute MI readmissions

For the past few years, the Centers for Medicare & Medicaid Services (CMS) has tracked 30-day readmissions rates for heart failure, acute MI and other conditions that account for a large percentage of readmissions. Hospitals that have excessive readmissions are subject to penalties.

Still, when it comes to readmissions for non-Medicare or Medicaid patients, there is a scarcity of data available. Recently, though, researchers examined the 2013 Nationwide Readmissions Database, which accounts for inpatient hospitalizations in 21 states and represents 49 percent of the U.S. population.

Their conclusions? Readmissions are not only frustrating and potentially devastating for patients, but they are also expensive for whoever is footing the bill.

Of the more than 14 million hospitalizations in the database, the researchers identified more than 1.1 million admissions that were associated with unplanned 30-day readmissions. Of the readmissions, 1.3 percent of patients were diagnosed with acute MI and 6.7 percent were diagnosed with heart failure.

The mean length of stays in the hospital were 5.7 days for acute MI and 6.4 days for heart failure, while the mean costs per readmission were $9,424 and $9,051, respectively.

The results were similar when the researchers performed sensitivity analyses based on expanded CMS discharge fields. With that criteria, they found that the mean length of stays in the hospital were 6.0 days for acute MI and 6.5 days for heart failure, while the mean costs per readmission were $9,530 and $9,248, respectively.

The researchers acknowledged that the National Readmission Database only used state-specific identifiers, so they could not follow-up patients across states. Thus, the readmission rates could have been higher. Still, the study should help hospitals, physicians and patients understand the economic impact of readmissions for two common cardiovascular conditions.

Tim Casey,

Executive Editor

Tim Casey joined TriMed Media Group in 2015 as Executive Editor. For the previous four years, he worked as an editor and writer for HMP Communications, primarily focused on covering managed care issues and reporting from medical and health care conferences. He was also a staff reporter at the Sacramento Bee for more than four years covering professional, college and high school sports. He earned his undergraduate degree in psychology from the University of Notre Dame and his MBA degree from Georgetown University.

Around the web

Tom Price, MD, former secretary of Health and Human Services (HHS), said one way to address the growing shortage of physicians is to expand medical resident positions, but these are tied to Medicare spending so alternative means may be needed.

"Domestic radiopharmaceutical suppliers, who receive isotopes from abroad, would be impacted by price changes and uncertainty caused by additional tariffs,” SNMMI President Cathy Cutler, PhD, wrote in a letter to the U.S. Department of Commerce this week.

If President Trump initiates a 25% tariff against pharmaceuticals imported from Ireland, it might impact the price for X-ray iodine contrast agents in the U.S. depending what rules are put in place.